Your session is about to expire
← Back to Search
Exercise Intervention for Childhood Cancer Survivors
Study Summary
This trial will test whether adding an exercise intervention to standard cancer care can improve pain, function, and quality of life for young cancer survivors.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been experiencing pain for over 3 months, and it's at least a 1 out of 10.I can understand and agree to the study's requirements.I finished my cancer treatment less than a year ago.My cancer has come back or didn't respond to treatment.I finished my cancer treatment more than a year ago.I am older than 17 years.I have finished all my cancer treatments and my condition is stable.I am still undergoing cancer treatment or not in complete remission.I can walk with or without assistance.I have been diagnosed with cancer.I am a childhood cancer survivor aged between 10 and 17.
- Group 1: Physical activity intervention coupled with standard post-cancer directed treatment care group
- Group 2: Standard post-cancer directed treatment care control group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does the age requirement for participants extend to those under 25 years old?
"To qualify for this trial, prospective candidates must be between 10 and 17 years old. In addition, there are two clinical trials specifically targeting minors and three seeking the elderly population."
Are there vacancies available for potential participants in this research endeavor?
"According to the information on clinicialtrials.gov, this experiment is not currently registering participants; however it was initially advertised in November of 2023 and last updated in September of 2022. Although there are no open spots for enrollment at present, five other medical trials are actively seeking volunteers."
What key aims is this study hoping to achieve?
"The primary end point of this clinical trial, assessed over 16 weeks, is to evaluate the acceptability of the intervention. Secondary objectives include charting changes in cumulative dose and usage of pain medications (prescription or non-prescription), as well as a Morphine equivalent dose tally for each patient. Additionally, chronic pain levels will be monitored with a PedsQL questionnaire and physical activity level via a Godin-Shephard leisure time questionnaire."
Who is able to be accepted into this medical experiment?
"This study necessitates the recruitment of 20 juvenile cancer survivors between the designated ages. Necessary qualifications for participation include: gender identity, being less than one year past their treatment, having persistent pain lasting 3 months or more, fluency in English (for both patient and legal guardian), parental/legal guardianship consent to participate and assent from the participant themselves, attendance at baseline assessment as well as 8-week and 16-week follow up visits at Penn State Health Children's Hospital, full remission status during enrollment process, age requirements between 10 - 17 years old when enrolling , and lastly whether they are able to ambulate or"
Share this study with friends
Copy Link
Messenger